SCHEMBL4158539

SCHEMBL4158539

CONC(=O)N(C)c1ccc(SC(F)(F)F)cc1F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.36
HTT P42858 2/20 0.36
LMNA P02545 2/20 0.36
TSHR P16473 1/20 0.36
MAPK1 P28482 1/20 0.36
KIF11 P52732 1/20 0.35
KCNK2 O95069 4/20 0.35
KCNK10 P57789 2/20 0.35
RXFP1 Q9HBX9 1/20 0.33
TRPV1 Q8NER1 1/20 0.33
ABCB1 P08183 1/20 0.32
ABCC1 P33527 1/20 0.32
PTPRZ1 P23471 1/20 0.32
MCHR1 Q99705 1/20 0.32
ALDH1A1 P00352 2/20 0.32
KDM4E B2RXH2 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
PDE2A O00408 1/20 0.31
EPHX2 P34913 1/20 0.31
NR1H4 Q96RI1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4149723 0.85 TSHR (0.38) MAPTHTTLMNATSHRMAPK1
SCHEMBL4142460 0.84 LMNA (0.35) MAPTHTTLMNATSHRMAPK1
SCHEMBL4149900 0.84 MCHR1 (0.36) MAPTHTTLMNATSHRMAPK1
SCHEMBL4144820 0.84 PTPRZ1 (0.35) MAPTHTTLMNATSHRMAPK1
SCHEMBL13774526 0.82 MCHR1 (0.37) MAPTLMNAKCNK2KCNK10PTPRZ1
SCHEMBL4142022 0.82 PTPRZ1 (0.37) MAPTHTTLMNATSHRMAPK1
SCHEMBL4145099 0.81 KMT2A (0.34) KCNK2KCNK10ABCB1ABCC1PTPRZ1
SCHEMBL4150851 0.81 PTPRZ1 (0.36) MAPTHTTLMNATSHRMAPK1
SCHEMBL3618932 0.81 FSCN1 (0.44) MAPTHTTLMNATSHRMAPK1
SCHEMBL4154041 0.80 EPHX2 (0.39) MAPTHTTLMNATSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
EP-1937629-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-07-02 EP disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176786-A1 Benzoylurea Compounds and Use Thereof BTK, BRIX1, NFXL1 MAPT 4585/4885HTT 2562/4885LMNA 2141/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.